Recent Finacing
Recent Raise
CellProthera develops ProtheraCytes, CD34+ cells derived from a blood test to repair post‑myocardial infarction heart tissue, conducting clinical trials while building scalable manufacturing and regional therapy centers.
Focus Areas
Total Raised
Funding round